VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Postdoctoral Scientist, Multimodal Single Cell Foundation Models

Johnson & Johnson Innovative Medicine is dedicated to healthcare innovation, focused on developing treatments and cures for complex diseases. The Postdoctoral Scientist will lead the development of advanced disease models, collaborate with multidisciplinary teams, and provide innovative insights through computational modeling of biological processes.

Sign up with Google

Sign in with Google